Crescent Biopharma Inc banner

Intrinsic Value

Not Available for C68

There is not enough data to reliably calculate the intrinsic value for Crescent Biopharma Inc.

Do our valuations actually work? See backtest results .

Alternatives to C68

Fundamental Analysis

What Crescent Biopharma Does

Biotechnology Health Care

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates.

Headquarters
United States of America US
Employees
4
IPO date
Jan 10, 2014
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue C68 Research

Decided on Crescent Biopharma? Get an email when C68 reaches the price you’d buy at. Free with an account.

Back to Top